Lung cancer is one of the leading causes of cancer death among men and women in the US. One option […]
Researchers have shown that relaxing the eligibility criteria of clinical trials in a data-driven manner can significantly increase the number […]
Proteolysis-targeting chimeras (PROTACs) are an emerging class of drugs that may offer new opportunities to overcome limitations associated with small-molecule […]
The Swiss Personalised Health Network developed a flexible, pragmatic framework that promotes interoperability between diverse biomedical datasets. The proposed three-pillar […]
For the first time, a review explored in depth how big data and artificial intelligence (AI) techniques are currently being […]
Researchers from the University of Virginia School of Medicine have developed a new database of transcriptional regulators, which will help […]
Description of transcriptomic alterations in Huntington’s disease is essential for the identification of targets for biomedical studies and drug development. […]
Earlier this week the U.S. Food and Drug Administration approved the first new treatment for Alzheimer’s disease in almost 20 […]
One of the most prominent topics in drug discovery is the efficient exploration of the vast number of drug-like chemicals […]
Regulatory agencies have recommended designing more representative trials of anti-diabetic drugs, but this first requires defining clinically relevant target populations […]
